glp 1 receptor drugs Is GLP-1 Safe for Weight Loss? Peptides, Benefits & Risks GLP-1 Receptor Agonist Market Size
Description
Glucagon-like peptide 1 receptor (GLP1R) is a GPCR drug target found in the pancreas and on neurons of the brain
Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide agonists and other metabolic hormones for the treatment of chronic kidney disease
Health Canada Details DIN Checks, CBSA Role in GLP-1 Advisory Health Canada's public advisory on unauthorized and counterfeit GLP-1 receptor agonist products, last updated January 21, 2026, instructs Canadians to verify any prescription product by checking for an eight-digit Drug Identification Number (DIN) on the label and searching Health Canada's Drug Product Database before purchase [Source: recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized]
For instance, Hulst et al (2021)178 recommended continuation of all GLP-1RAs therapies throughout the perioperative period
This is where Listen Labs can help
[DOI] [PubMed] [Google Scholar] 66.Packer M, et al
